CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancerMaría Otero‐Rosales, Francisco Hermida‐Prado, Esperanza Pozo-Agundo et al.|Signal Transduction and Targeted Therapy|2025Cited by 2
Genome-wide functional CRISPR screen reveals CDK7 as a targetable therapeutic vulnerability for head and neck cancerMaría Otero‐Rosales, Francisco Hermida‐Prado, Miguel Álvarez-González et al.|Research Square|2024Cited by 0